ReviewHistology and histopathology2020
Evaluating Trastuzumab in the treatment of HER2 positive breast cancer.
Ryan Jaques et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
3 papers cite it
this papercites it
ReviewHistology and histopathology2020
Ryan Jaques et al.PubMed ↗Publisher ↗
No numbers read from the abstract.